Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4284]

Study identifies new protection mechanism in breast cancer

Study identifies new protection mechanism in breast cancer

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited...

Drug prevents human breast cancer recurrence and metastasis

Drug prevents human breast cancer recurrence and metastasis

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Overcoming resistance to breast cancer treatment

Overcoming resistance to breast cancer treatment

Ribociclib added to endocrine therapy extends survival in postmenopausal patients with metastatic breast cancer

Ribociclib added to endocrine therapy extends survival in postmenopausal patients with metastatic breast cancer

Triple-negative breast cancer: Survival advantage with sacituzumab govitecan

Triple-negative breast cancer: Survival advantage with sacituzumab govitecan

Promising approach against treatment-resistant cancer

Promising approach against treatment-resistant cancer

Research team outlines new methods to identify personalised drug treatments for breast cancer

Research team outlines new methods to identify personalised drug treatments for breast cancer

How the immune system responds to tissue damage can aid cancer spread

How the immune system responds to tissue damage can aid cancer spread

More from ecancer